Skip to main content
. 2021 Jul 15;7(9):1368–1377. doi: 10.1001/jamaoncol.2021.2209

Figure 2. Kaplan-Meier Curves for Overall Survival and Progression-Free Survival .

Figure 2.

A, Overall survival for nivolumab vs nivolumab plus ipilimumab. B, Progression-free survival for nivolumab vs nivolumab plus ipilimumab. Tick marks represent censored observations.